Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.

Bhattacharyya S, Sekar V, Majumder B, Mehrotra DG, Banerjee S, Bhowmick AK, Alam N, Mandal GK, Biswas J, Majumder PK, Murmu N.

Cell Oncol (Dordr). 2017 Apr;40(2):145-155. doi: 10.1007/s13402-016-0311-7. Epub 2016 Dec 30.

PMID:
28039610
2.

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.

Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani M, Brijwani N, Pinto DD, Prasath A, Shanthappa BU, Thayakumar A, Surendran R, Babu GK, Shenoy AM, Kuriakose MA, Bergthold G, Horowitz P, Loda M, Beroukhim R, Agarwal S, Sengupta S, Sundaram M, Majumder PK.

Nat Commun. 2015 Feb 27;6:6169. doi: 10.1038/ncomms7169.

3.

Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition.

Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S.

Nat Commun. 2015 Feb 11;6:6139. doi: 10.1038/ncomms7139.

4.

Inhibition of rapamycin-induced AKT activation elicits differential antitumor response in head and neck cancers.

Radhakrishnan P, Baraneedharan U, Veluchamy S, Dhandapani M, Pinto DD, Thiyagarajan S, Thayakumar A, Prasath A, A K, Velu A, Jain M, Brijwani N, Narayanan P, Kekatpure VD, Majumder B, Majumder PK.

Cancer Res. 2013 Feb 1;73(3):1118-27. doi: 10.1158/0008-5472.CAN-12-2545. Epub 2013 Jan 29.

5.

Evidence of mTOR Activation by an AKT-Independent Mechanism Provides Support for the Combined Treatment of PTEN-Deficient Prostate Tumors with mTOR and AKT Inhibitors.

Zhang W, Haines BB, Efferson C, Zhu J, Ware C, Kunii K, Tammam J, Angagaw M, Hinton MC, Keilhack H, Paweletz CP, Zhang T, Winter C, Sathyanarayanan S, Cheng J, Zawel L, Fawell S, Gilliland G, Majumder PK.

Transl Oncol. 2012 Dec;5(6):422-9. Epub 2012 Dec 1.

6.

Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.

Kondratyev M, Kreso A, Hallett RM, Girgis-Gabardo A, Barcelon ME, Ilieva D, Ware C, Majumder PK, Hassell JA.

Oncogene. 2012 Jan 5;31(1):93-103. doi: 10.1038/onc.2011.212. Epub 2011 Jun 13.

PMID:
21666715
7.

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity.

Chandarlapaty S, Sawai A, Scaltriti M, Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V, Majumder PK, Baselga J, Rosen N.

Cancer Cell. 2011 Jan 18;19(1):58-71. doi: 10.1016/j.ccr.2010.10.031. Epub 2011 Jan 6.

8.

MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.

Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, Ueno Y, Hatch H, Majumder PK, Pan BS, Kotani H.

Mol Cancer Ther. 2010 Jul;9(7):1956-67. doi: 10.1158/1535-7163.MCT-09-1012. Epub 2010 Jun 22.

9.

Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.

Efferson CL, Winkelmann CT, Ware C, Sullivan T, Giampaoli S, Tammam J, Patel S, Mesiti G, Reilly JF, Gibson RE, Buser C, Yeatman T, Coppola D, Winter C, Clark EA, Draetta GF, Strack PR, Majumder PK.

Cancer Res. 2010 Mar 15;70(6):2476-84. doi: 10.1158/0008-5472.CAN-09-3114. Epub 2010 Mar 2.

10.

De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor model.

Watters JW, Cheng C, Majumder PK, Wang R, Yalavarthi S, Meeske C, Kong L, Sun W, Lin J, Heyer J, Ware C, Winter C, Reilly JF, Demuth T, Clark S, Chiu MI, Robinson MO, Kohl N, Kannan K.

Cancer Res. 2009 Dec 1;69(23):8949-57. doi: 10.1158/0008-5472.CAN-09-1544. Epub 2009 Nov 10.

11.

Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia.

Tammam J, Ware C, Efferson C, O'Neil J, Rao S, Qu X, Gorenstein J, Angagaw M, Kim H, Kenific C, Kunii K, Leach KJ, Nikov G, Zhao J, Dai X, Hardwick J, Scott M, Winter C, Bristow L, Elbi C, Reilly JF, Look T, Draetta G, Van der Ploeg L, Kohl NE, Strack PR, Majumder PK.

Br J Pharmacol. 2009 Nov;158(5):1183-95. doi: 10.1111/j.1476-5381.2009.00389.x. Epub 2009 Sep 23.

12.

Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer.

Zhang W, Zhu J, Efferson CL, Ware C, Tammam J, Angagaw M, Laskey J, Bettano KA, Kasibhatla S, Reilly JF, Sur C, Majumder PK.

Cancer Res. 2009 Sep 15;69(18):7466-72. doi: 10.1158/0008-5472.CAN-08-4385. Epub 2009 Sep 8.

13.

Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.

Cullion K, Draheim KM, Hermance N, Tammam J, Sharma VM, Ware C, Nikov G, Krishnamoorthy V, Majumder PK, Kelliher MA.

Blood. 2009 Jun 11;113(24):6172-81. doi: 10.1182/blood-2008-02-136762. Epub 2009 Feb 26.

14.

Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma.

Plentz R, Park JS, Rhim AD, Abravanel D, Hezel AF, Sharma SV, Gurumurthy S, Deshpande V, Kenific C, Settleman J, Majumder PK, Stanger BZ, Bardeesy N.

Gastroenterology. 2009 May;136(5):1741-9.e6. doi: 10.1053/j.gastro.2009.01.008. Epub 2009 Jan 14.

15.

A frequency stabilization technique for diode lasers based on frequency-shifted beams from an acousto-optic modulator.

Gunawardena M, Hess PW, Strait J, Majumder PK.

Rev Sci Instrum. 2008 Oct;79(10):103110. doi: 10.1063/1.3006386.

PMID:
19044705
16.

A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek WK, Wang S, Ellwood-Yen K, Wu H, Sawyers CL, Signoretti S, Hahn WC, Loda M, Sellers WR.

Cancer Cell. 2008 Aug 12;14(2):146-55. doi: 10.1016/j.ccr.2008.06.002.

17.

Identification of prostate cancer modifier pathways using parental strain expression mapping.

Xu Q, Majumder PK, Ross K, Shim Y, Golub TR, Loda M, Sellers WR.

Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17771-6. Epub 2007 Oct 31.

18.

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes.

Das H, Kumar A, Lin Z, Patino WD, Hwang PM, Feinberg MW, Majumder PK, Jain MK.

Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6653-8. Epub 2006 Apr 14.

19.

Akt-regulated pathways in prostate cancer.

Majumder PK, Sellers WR.

Oncogene. 2005 Nov 14;24(50):7465-74. Review.

PMID:
16288293
20.

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.

Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M, Golub TR, Hahn WC.

Cancer Res. 2004 Dec 15;64(24):8867-75.

21.

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.

Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, Loda M, Lane HA, Sellers WR.

Nat Med. 2004 Jun;10(6):594-601. Epub 2004 May 23.

PMID:
15156201
22.

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.

Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q, Bikoff R, Ma H, Kantoff PW, Golub TR, Loda M, Sellers WR.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7841-6. Epub 2003 Jun 10.

23.

In vivo modulation of androgen receptor by androgens.

Kumar VL, Majumder PK, Kumar V.

Asian J Androl. 2002 Sep;4(3):229-31.

24.

Targeting of protein kinase C delta to mitochondria in the oxidative stress response.

Majumder PK, Mishra NC, Sun X, Bharti A, Kharbanda S, Saxena S, Kufe D.

Cell Growth Differ. 2001 Sep;12(9):465-70.

25.

Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase.

Kumar V, Sabatini D, Pandey P, Gingras AC, Majumder PK, Kumar M, Yuan ZM, Carmichael G, Weichselbaum R, Sonenberg N, Kufe D, Kharbanda S.

J Biol Chem. 2000 Apr 14;275(15):10779-87.

26.

Observations on EGFR gene amplification and polymorphism in prostatic diseases.

Kumar VL, Majumder PK, Kumar V.

Int Urol Nephrol. 2000;32(1):73-5.

PMID:
11057777
27.

Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis.

Majumder PK, Pandey P, Sun X, Cheng K, Datta R, Saxena S, Kharbanda S, Kufe D.

J Biol Chem. 2000 Jul 21;275(29):21793-6.

28.

Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation.

Kumar V, Pandey P, Sabatini D, Kumar M, Majumder PK, Bharti A, Carmichael G, Kufe D, Kharbanda S.

EMBO J. 2000 Mar 1;19(5):1087-97.

29.

An unusual foreign body (10 N. P. COIN) in nasopharynx.

Majumder PK, Sinha AK, Mookherje PB, Ganguly SN.

Indian J Otolaryngol Head Neck Surg. 1999 Dec;52(1):93. doi: 10.1007/BF02996448. No abstract available.

30.

Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism.

Pandey P, Avraham S, Kumar S, Nakazawa A, Place A, Ghanem L, Rana A, Kumar V, Majumder PK, Avraham H, Davis RJ, Kharbanda S.

J Biol Chem. 1999 Apr 9;274(15):10140-4.

31.
32.

Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate.

Kumar VL, Majumder PK, Gujral S, Kumar V.

Cancer Lett. 1998 Dec 25;134(2):177-80.

PMID:
10025878
33.
34.

Anti-steroidogenic activity of the petroleum ether extract and fraction 5 (fatty acids) of carrot (Daucus carota L.) seeds in mouse ovary.

Majumder PK, Dasgupta S, Mukhopadhaya RK, Mazumdar UK, Gupta M.

J Ethnopharmacol. 1997 Aug;57(3):209-12.

PMID:
9292415
35.

Androgen deprivation causes up-regulation of androgen receptor transcript in the rat prostate.

Kumar VL, Majumder PK, Kumar V.

Mol Cell Biochem. 1997 Jun;171(1-2):133-8.

PMID:
9201706
36.

Androgen receptor mRNA detection in the human foetal prostate.

Majumder PK, Kumar VL.

Int Urol Nephrol. 1997;29(6):633-5.

PMID:
9477359
37.

Androgen receptor transcript level in benign hypertrophy and carcinoma of the human prostate.

Majumder PK, Wadhwa SN, Kumar VL.

Urol Int. 1997;59(4):231-5.

PMID:
9444740
38.

Cardiovascular and respiratory changes following exposure to a synthetic toxin of Ptychodiscus brevis.

Koley J, Sinha S, Basak AK, Das M, Dube SN, Majumder PK, Gupta AK, Dasgupta S, Koley B.

Eur J Pharmacol. 1995 Dec 7;293(4):483-6.

PMID:
8748702
39.

Optical-rotation technique used for a high-precision measurement of parity nonconservation in atomic lead.

Meekhof DM, Vetter PA, Majumder PK, Lamoreaux SK, Fortson EN.

Phys Rev A. 1995 Sep;52(3):1895-1908. No abstract available.

PMID:
9912448
40.

Precise Test of Electroweak Theory from a New Measurement of Parity Nonconservation in Atomic Thallium.

Vetter PA, Meekhof DM, Majumder PK, Lamoreaux SK, Fortson EN.

Phys Rev Lett. 1995 Apr 3;74(14):2658-2661. No abstract available.

PMID:
10057985
41.

Inhibitory effects of formaldehyde on the reproductive system of male rats.

Majumder PK, Kumar VL.

Indian J Physiol Pharmacol. 1995 Jan;39(1):80-2.

PMID:
7705878
42.

Prostate gland: structure, functions and regulation.

Kumar VL, Majumder PK.

Int Urol Nephrol. 1995;27(3):231-43. Review.

PMID:
7591584
43.

High-precision measurement of parity nonconserving optical rotation in atomic lead.

Meekhof DM, Vetter P, Majumder PK, Lamoreaux SK, Fortson EN.

Phys Rev Lett. 1993 Nov 22;71(21):3442-3445. No abstract available.

PMID:
10054978
44.

Search for a coupling of the Earth's gravitational field to nuclear spins in atomic mercury.

Venema BJ, Majumder PK, Lamoreaux SK, Heckel BR, Fortson EN.

Phys Rev Lett. 1992 Jan 13;68(2):135-138. No abstract available.

PMID:
10045544
45.

Test of the linearity of quantum mechanics in optically pumped 201Hg.

Majumder PK, Venema BJ, Lamoreaux SK, Heckel BR, Fortson EN.

Phys Rev Lett. 1990 Dec 10;65(24):2931-2934. No abstract available.

PMID:
10042736
46.

New test of QED from a measurement of the 4 2S1/2-4 (2)F5/2 three-photon transition in He+

Majumder PK, Pipkin FM.

Phys Rev Lett. 1989 Jul 24;63(4):372-375. No abstract available.

PMID:
10041056
47.

Phase-variation technique for measurement of the n=2 Lamb shift in He+ using separated oscillatory fields.

Klein HA, Hagley EW, Majumder PK, Pipkin FM, Poitzsch ME.

Phys Rev A Gen Phys. 1987 Oct 1;36(7):3494-3496. No abstract available.

PMID:
9899280
48.
49.

The mechanism of progesterone-glucocorticoid interaction in regulation of casein gene expression.

Ganguly R, Majumder PK, Ganguly N, Banerjee MR.

J Biol Chem. 1982 Mar 10;257(5):2182-7. No abstract available.

50.

Relationships of protein and mineral intake to L-ascorbic acid metabolism, including considerations of some directly related hormones.

Chatterjee GC, Majumder PK, Banerjee SK, Roy RK, Ray B, Rudrapal D.

Ann N Y Acad Sci. 1975 Sep 30;258:382-400. Review. No abstract available.

PMID:
1106300

Supplemental Content

Loading ...
Support Center